Abstract
We assessed the utility of EBC pH as a biomarker in COPD in a large cohort of well-characterised individuals with COPD and control subjects from the Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) study. We also determined short term reproducibility and the response of EBC to oral prednisolone.
Original language | English |
---|---|
Pages (from-to) | 1037-45 |
Number of pages | 9 |
Journal | American Journal of Respiratory and Critical Care Medicine |
Volume | 105 |
Issue number | 7 |
DOIs | |
Publication status | Published - 2011 |